Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.
Establishing the Collaborative Care Model of Traditional Chinse Medicine and Western Medicine for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.
1 other identifier
interventional
60
1 country
1
Brief Summary
In this project,the investigators aim to establish a Collaborative Care Model of TCM and Western Medicine to improve the quality of life and symptoms of AR with OSA children and educate care-givers diet and massage information to improve self-care ability and alleviate anxiety for parents. In addition, the investigators will use portable oxymeter to detect the change of SpO2 and respiratory arousal index daily at home and evaluate sensitivity and specificity of portable oxymeter device applied in OSA. The investigators want to give holistic health care for participants and care-givers by this project. In addition, the investigators will build a training environment to provide medical education and training opportunity to teach medical students and clinician the knowledge of pediatric allergic rhinitis and obstructive sleep apnea by caring patients and learning from clinical cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2020
CompletedStudy Start
First participant enrolled
July 29, 2020
CompletedFirst Posted
Study publicly available on registry
November 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedNovember 9, 2020
November 1, 2020
1.4 years
July 29, 2020
November 3, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
The change of mean score of Obstructive Sleep Apnea-18 Questionnaire
Evaluation quality of life pediatric Obstructive Sleep Apnea-18 ,(score:0-108)
8 weeks
Secondary Outcomes (8)
The change of mean score of Sinus and Nasal Quality of Life Survey
8 weeks
The change of mean score of Pediatric Sleep Questionnaire
8 weeks
The change of mean score of SNAP IV ( Swanson, Nolan and Pelham questionnaire)
8 weeks
Apnea-Hypopnea Index
8 weeks
adeonid nasopharnygeal ratio
8 weeks
- +3 more secondary outcomes
Study Arms (2)
Collaborative Care Model of TCM and WM
EXPERIMENTALTraditional Chinese Medicine(TCM):laser acupuncture and massage education. Western Medicine (WM):intra-nasal corticosteroid with singulair
Western medicine
ACTIVE COMPARATORWestern Medicine (WM):intra-nasal corticosteroid with singulair
Interventions
use a low-level-laser acupuncture on acupoint
Montelukast 4mg 1 tablet HS AVAMYS nasal spray 27.5μg QD
Eligibility Criteria
You may qualify if:
- Age less than 18 years old
- Patients with persistent, moderate to severe allergic rhinitis who have been diagnosed by ARIA (2014) diagnostic criteria
- AHI by polysomnography is \>1 and diagnosis with obstructive sleep apnea.
You may not qualify if:
- Abnormal craniofacial structure and require surgery.
- Patients with sleep apnea caused by muscular dysplasia of the upper respiratory tract ( eg. cerebral palsy, Down syndrome, and other congenital muscular hypoplasia).
- Mental or behavioral abnormalities that cannot cooperate with the researcher, such as schizophrenia, depression, suicidal ideation, etc.
- Allergy to the treatment previously
- Any disease or organ system dysfunction that may be life-threatening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University & Hospital
Taichung, 40447, Taiwan
MeSH Terms
Interventions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Division of Chinese Medicine Pediatrics
Study Record Dates
First Submitted
July 29, 2020
First Posted
November 9, 2020
Study Start
July 29, 2020
Primary Completion
December 16, 2021
Study Completion
December 31, 2022
Last Updated
November 9, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share